FOXA1 and prostate disorder: Foxa1 genetic ablation causes loss of luminal secretory cells, prostatic hyperplasia and transdifferentiation, in line with an instructing role of Foxa1 in luminal lineage commitment (Gao et al, 2005; DeGraff et al, 2014).